Innoviva, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Burlingame, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Innoviva, Inc. has filed 1,661 SEC EDGAR filings since 21 Mar 2000

SEC filing history

Showing 701-725 of 1,000 matching filings.

Per page
25
Current page
29
4

FORM 4 -

Filing date
09 Jan 2015
Reporting date
07 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
09 Jan 2015
Reporting date
07 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
09 Jan 2015
Reporting date
07 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Dec 2014
Reporting date
22 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Dec 2014
Reporting date
22 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Dec 2014
Reporting date
22 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Dec 2014
Reporting date
22 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

THERAVANCE, INC.

Filing date
23 Dec 2014
Reporting date
23 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

THERAVANCE 8K

Filing date
01 Dec 2014
Reporting date
01 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

THERAVANCE, INC. 8-K

Filing date
19 Nov 2014
Reporting date
19 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

THERAVANCE, INC. 8-K

Filing date
13 Nov 2014
Reporting date
13 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-80415

SC 13D/A filing

Filing date
04 Nov 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Nov 2014
Reporting date
04 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Nov 2014
Reporting date
30 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
03 Nov 2014
Reporting date
30 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

THERAVANCE, INC. 8-K

Filing date
30 Oct 2014
Reporting date
30 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

8-K

Filing date
28 Oct 2014
Reporting date
28 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

8-K

Filing date
27 Oct 2014
Reporting date
26 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

THERAVANCE, INC. 8-K

Filing date
21 Oct 2014
Reporting date
21 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
17 Oct 2014
Reporting date
16 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

THERAVANCE, INC. 8K

Filing date
17 Oct 2014
Reporting date
17 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
15 Oct 2014
Reporting date
09 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

THERAVANCE INC.

Filing date
09 Oct 2014
Reporting date
09 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-30319

CT ORDER filing

Filing date
01 Oct 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .